Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Yachie-Kinoshita A"'
Autor:
Jiang, Shuo, Evans-Yamamoto, Daniel, Bersenev, Dennis, Palaniappan, Sucheendra K., Yachie-Kinoshita, Ayako
Protocol standardization and sharing are crucial for reproducibility in life sciences. In spite of numerous efforts for standardized protocol description, adherence to these standards in literature remains largely inconsistent. Curation of protocols
Externí odkaz:
http://arxiv.org/abs/2312.06241
Autor:
Shuo Jiang, Daniel Evans-Yamamoto, Dennis Bersenev, Sucheendra K. Palaniappan, Ayako Yachie-Kinoshita
Publikováno v:
SLAS Technology, Vol 29, Iss 3, Pp 100134- (2024)
Protocol standardization and sharing are crucial for reproducibility in life sciences. In spite of numerous efforts for standardized protocol description, adherence to these standards in literature remains largely inconsistent. Curation of protocols
Externí odkaz:
https://doaj.org/article/a4d198cb942043508ee76eab41c00e7e
Autor:
Jiang, Shuo, Evans-Yamamoto, Daniel, Bersenev, Dennis, Palaniappan, Sucheendra K., Yachie-Kinoshita, Ayako
Publikováno v:
In SLAS Technology June 2024 29(3)
Autor:
Shingo Tsuji, Takeshi Hase, Ayako Yachie-Kinoshita, Taiko Nishino, Samik Ghosh, Masataka Kikuchi, Kazuro Shimokawa, Hiroyuki Aburatani, Hiroaki Kitano, Hiroshi Tanaka
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-15 (2021)
Abstract Background Identifying novel therapeutic targets is crucial for the successful development of drugs. However, the cost to experimentally identify therapeutic targets is huge and only approximately 400 genes are targets for FDA-approved drugs
Externí odkaz:
https://doaj.org/article/9f86af9cd7f64393aab1f2c94cd69a8e
Autor:
Tiam Heydari, Matthew A Langley, Cynthia L Fisher, Daniel Aguilar-Hidalgo, Shreya Shukla, Ayako Yachie-Kinoshita, Michael Hughes, Kelly M McNagny, Peter W Zandstra
Publikováno v:
PLoS Computational Biology, Vol 18, Iss 2, p e1009907 (2022)
The increasing availability of single-cell RNA-sequencing (scRNA-seq) data from various developmental systems provides the opportunity to infer gene regulatory networks (GRNs) directly from data. Herein we describe IQCELL, a platform to infer, simula
Externí odkaz:
https://doaj.org/article/ac7a7750987c4461be0be648a96584c1
Autor:
Ayako Yachie‐Kinoshita, Kento Onishi, Joel Ostblom, Matthew A Langley, Eszter Posfai, Janet Rossant, Peter W Zandstra
Publikováno v:
Molecular Systems Biology, Vol 14, Iss 1, Pp 1-16 (2018)
Abstract Pluripotent stem cells (PSCs) exist in multiple stable states, each with specific cellular properties and molecular signatures. The mechanisms that maintain pluripotency, or that cause its destabilization to initiate development, are complex
Externí odkaz:
https://doaj.org/article/636e86fc8cc5407ea6b8435720f6b893
Autor:
Yu Kato, Kimiyo Tabata, Takayuki Kimura, Ayako Yachie-Kinoshita, Yoichi Ozawa, Kazuhiko Yamada, Junichi Ito, Sho Tachino, Yusaku Hori, Masahiro Matsuki, Yukiko Matsuoka, Samik Ghosh, Hiroaki Kitano, Kenichi Nomoto, Junji Matsui, Yasuhiro Funahashi
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0212513 (2019)
Lenvatinib is a multiple receptor tyrosine kinase inhibitor targeting mainly vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) receptors. We investigated the immunomodulatory activities of lenvatinib in the tumor microenvir
Externí odkaz:
https://doaj.org/article/a3add2de47a44a519a9f34fb4324f9ca
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nishino, Taiko, Yachie-Kinoshita, Ayako, Hirayama, Akiyoshi, Soga, Tomoyoshi, Suematsu, Makoto, Tomita, Masaru
Publikováno v:
In Journal of Biotechnology 2009 144(3):212-223
Autor:
Ayako Yachie-Kinoshita, Shingo Tsuji, Kazuro Shimokawa, Hiroyuki Aburatani, Masataka Kikuchi, Samik Ghosh, Hiroshi Tanaka, Taiko Nishino, Hiroaki Kitano, Takeshi Hase
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-15 (2021)
Alzheimer's Research & Therapy
Alzheimer's Research & Therapy
Background Identifying novel therapeutic targets is crucial for the successful development of drugs. However, the cost to experimentally identify therapeutic targets is huge and only approximately 400 genes are targets for FDA-approved drugs. As a re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5983c3a82e07b2153a133abcfc77aa4a
https://doi.org/10.1186/s13195-021-00826-3
https://doi.org/10.1186/s13195-021-00826-3